Kronox Lab Sciences Limited (NSE:KRONOX)
India
· Delayed Price · Currency is INR 166.35
+1.55 (0.94%)
Last updated: May 28, 2025
Kronox Lab Sciences Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 |
| Operating Revenue | 1,002 | 898.62 | 955.78 | 822.47 | 624.6 | Upgrade
|
| Other Revenue | - | - | - | 1.33 | 1.59 | Upgrade
|
| Revenue | 1,002 | 898.62 | 955.78 | 823.8 | 626.19 | Upgrade
|
| Revenue Growth (YoY) | 11.50% | -5.98% | 16.02% | 31.56% | 23.29% | Upgrade
|
| Cost of Revenue | 509.23 | 462.54 | 552.62 | 477 | 347.08 | Upgrade
|
| Gross Profit | 492.71 | 436.09 | 403.16 | 346.8 | 279.11 | Upgrade
|
| Selling, General & Admin | 47.54 | 62.29 | 70.27 | 57.82 | 54.34 | Upgrade
|
| Other Operating Expenses | 113.9 | 87.16 | 113.05 | 87.73 | 73.21 | Upgrade
|
| Operating Expenses | 175.26 | 162.33 | 198.28 | 165.84 | 147.31 | Upgrade
|
| Operating Income | 317.45 | 273.75 | 204.88 | 180.96 | 131.8 | Upgrade
|
| Interest Expense | - | - | -0.93 | -4.05 | -3.82 | Upgrade
|
| Interest & Investment Income | - | 10.17 | 4.25 | 3.2 | 2.78 | Upgrade
|
| Currency Exchange Gain (Loss) | - | 2.16 | 9.48 | 3.17 | 0.95 | Upgrade
|
| Other Non Operating Income (Expenses) | 25.26 | - | -0 | 0.01 | 0.23 | Upgrade
|
| EBT Excluding Unusual Items | 342.71 | 286.08 | 217.68 | 183.29 | 131.94 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | 0.11 | 0.26 | 0.27 | Upgrade
|
| Other Unusual Items | - | - | 2.62 | - | - | Upgrade
|
| Pretax Income | 342.71 | 286.08 | 220.41 | 183.55 | 132.21 | Upgrade
|
| Income Tax Expense | 88.04 | 72.57 | 56.38 | 47.28 | 34.91 | Upgrade
|
| Net Income | 254.67 | 213.51 | 164.03 | 136.27 | 97.3 | Upgrade
|
| Net Income to Common | 254.67 | 213.51 | 164.03 | 136.27 | 97.3 | Upgrade
|
| Net Income Growth | 19.28% | 30.16% | 20.37% | 40.05% | 14.14% | Upgrade
|
| Shares Outstanding (Basic) | 37 | 37 | 39 | 39 | 40 | Upgrade
|
| Shares Outstanding (Diluted) | 37 | 37 | 39 | 39 | 40 | Upgrade
|
| Shares Change (YoY) | -0.67% | -4.09% | -0.91% | -3.59% | -0.01% | Upgrade
|
| EPS (Basic) | 6.91 | 5.75 | 4.24 | 3.49 | 2.40 | Upgrade
|
| EPS (Diluted) | 6.91 | 5.75 | 4.24 | 3.49 | 2.40 | Upgrade
|
| EPS Growth | 20.08% | 35.72% | 21.49% | 45.42% | 14.02% | Upgrade
|
| Free Cash Flow | 275.92 | 51.45 | 112.5 | 52.24 | 96.64 | Upgrade
|
| Free Cash Flow Per Share | 7.49 | 1.39 | 2.91 | 1.34 | 2.39 | Upgrade
|
| Dividend Per Share | 0.500 | 0.500 | - | - | - | Upgrade
|
| Gross Margin | 49.18% | 48.53% | 42.18% | 42.10% | 44.57% | Upgrade
|
| Operating Margin | 31.68% | 30.46% | 21.44% | 21.97% | 21.05% | Upgrade
|
| Profit Margin | 25.42% | 23.76% | 17.16% | 16.54% | 15.54% | Upgrade
|
| Free Cash Flow Margin | 27.54% | 5.73% | 11.77% | 6.34% | 15.43% | Upgrade
|
| EBITDA | 331.27 | 286.27 | 218.21 | 191.41 | 141.72 | Upgrade
|
| EBITDA Margin | 33.06% | 31.86% | 22.83% | 23.23% | 22.63% | Upgrade
|
| D&A For EBITDA | 13.82 | 12.51 | 13.33 | 10.45 | 9.92 | Upgrade
|
| EBIT | 317.45 | 273.75 | 204.88 | 180.96 | 131.8 | Upgrade
|
| EBIT Margin | 31.68% | 30.46% | 21.44% | 21.97% | 21.05% | Upgrade
|
| Effective Tax Rate | 25.69% | 25.37% | 25.58% | 25.76% | 26.41% | Upgrade
|
| Revenue as Reported | 1,027 | 914.4 | 974.98 | 833.4 | 632.36 | Upgrade
|
Updated Jan 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.